Real-World check: does the CLL drug acalabrutinib live up to hype?
NCT ID NCT05437250
First seen Jan 07, 2026 · Last updated May 22, 2026 · Updated 27 times
Summary
This study watches 350 people with chronic lymphocytic leukemia (CLL) who are taking the drug acalabrutinib as part of their normal care. Researchers want to see how long patients stay on the drug, why they stop, and how well it works outside of a strict research setting. The goal is to understand the drug's real-world benefits and risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Aix-en-Provence, France
-
Research Site
Amiens, France
-
Research Site
Angers, France
-
Research Site
Ars-Laquenexy, France
-
Research Site
Avignon, France
-
Research Site
Besançon, France
-
Research Site
Béziers, France
-
Research Site
Bobigny, France
-
Research Site
Bourg-en-Bresse, France
-
Research Site
Brest, France
-
Research Site
Caen, France
-
Research Site
Cahors, France
-
Research Site
Carcassonne, France
-
Research Site
Cesson-Sévigné, France
-
Research Site
Chalon-sur-Saône, France
-
Research Site
Chambéry, France
-
Research Site
Clamart, France
-
Research Site
Clermont-Ferrand, France
-
Research Site
Corbeil-Essonnes, France
-
Research Site
Dunkirk, France
-
Research Site
Essey-lès-Nancy, France
-
Research Site
Grenoble, France
-
Research Site
La Chaussée-Saint-Victor, France
-
Research Site
La Tronche, France
-
Research Site
LE Chesnay-rocquencourt, France
-
Research Site
Le Kremlin-Bicêtre, France
-
Research Site
Le Mans, France
-
Research Site
Le Puy-en-Velay, France
-
Research Site
Lens, France
-
Research Site
Libourne, France
-
Research Site
Lille, France
-
Research Site
Limoges, France
-
Research Site
Lorient, France
-
Research Site
Marseille, France
-
Research Site
Meaux, France
-
Research Site
Melun, France
-
Research Site
Mont-de-Marsan, France
-
Research Site
Nantes, France
-
Research Site
Nevers, France
-
Research Site
Nîmes, France
-
Research Site
Orléans, France
-
Research Site
Paris, France
-
Research Site
Perpignan, France
-
Research Site
Pessac, France
-
Research Site
Périgueux, France
-
Research Site
Pontoise, France
-
Research Site
Reims, France
-
Research Site
Rennes, France
-
Research Site
Roubaix, France
-
Research Site
Rouen, France
-
Research Site
Saumur, France
-
Research Site
Tarbes, France
-
Research Site
Toulouse, France
-
Research Site
Tours, France
-
Research Site
Trévenans, France
-
Research Site
Troyes, France
-
Research Site
Valence, France
-
Research Site
Vandœuvre-lès-Nancy, France
-
Research Site
Vantoux, France
-
Research Site
Vesoul, France
-
Research Site
Vichy, France
Conditions
Explore the condition pages connected to this study.